Tudor, D.V.; Bâldea, I.; Olteanu, D.E.; Fischer-Fodor, E.; Piroska, V.; Lupu, M.; Călinici, T.; Decea, R.M.; Filip, G.A.
Celecoxib as a Valuable Adjuvant in Cutaneous Melanoma Treated with Trametinib. Int. J. Mol. Sci. 2021, 22, 4387.
https://doi.org/10.3390/ijms22094387
AMA Style
Tudor DV, Bâldea I, Olteanu DE, Fischer-Fodor E, Piroska V, Lupu M, Călinici T, Decea RM, Filip GA.
Celecoxib as a Valuable Adjuvant in Cutaneous Melanoma Treated with Trametinib. International Journal of Molecular Sciences. 2021; 22(9):4387.
https://doi.org/10.3390/ijms22094387
Chicago/Turabian Style
Tudor, Diana Valentina, Ioana Bâldea, Diana Elena Olteanu, Eva Fischer-Fodor, Virag Piroska, Mihai Lupu, Tudor Călinici, Roxana Maria Decea, and Gabriela Adriana Filip.
2021. "Celecoxib as a Valuable Adjuvant in Cutaneous Melanoma Treated with Trametinib" International Journal of Molecular Sciences 22, no. 9: 4387.
https://doi.org/10.3390/ijms22094387
APA Style
Tudor, D. V., Bâldea, I., Olteanu, D. E., Fischer-Fodor, E., Piroska, V., Lupu, M., Călinici, T., Decea, R. M., & Filip, G. A.
(2021). Celecoxib as a Valuable Adjuvant in Cutaneous Melanoma Treated with Trametinib. International Journal of Molecular Sciences, 22(9), 4387.
https://doi.org/10.3390/ijms22094387